411 related articles for article (PubMed ID: 18063827)
21. Disruption of methylarginine metabolism impairs vascular homeostasis.
Leiper J; Nandi M; Torondel B; Murray-Rust J; Malaki M; O'Hara B; Rossiter S; Anthony S; Madhani M; Selwood D; Smith C; Wojciak-Stothard B; Rudiger A; Stidwill R; McDonald NQ; Vallance P
Nat Med; 2007 Feb; 13(2):198-203. PubMed ID: 17273169
[TBL] [Abstract][Full Text] [Related]
22. The biology and therapeutic potential of the DDAH/ADMA pathway.
Arrigoni F; Ahmetaj B; Leiper J
Curr Pharm Des; 2010; 16(37):4089-102. PubMed ID: 21247398
[TBL] [Abstract][Full Text] [Related]
23. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension.
Okubo K; Hayashi K; Wakino S; Matsuda H; Kubota E; Honda M; Tokuyama H; Yamamoto T; Kajiya F; Saruta T
Hypertens Res; 2005 Feb; 28(2):181-9. PubMed ID: 16025746
[TBL] [Abstract][Full Text] [Related]
24. Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells.
Novella S; Laguna-Fernández A; Lázaro-Franco M; Sobrino A; Bueno-Betí C; Tarín JJ; Monsalve E; Sanchís J; Hermenegildo C
Mol Cell Endocrinol; 2013 Jan; 365(1):11-6. PubMed ID: 22982060
[TBL] [Abstract][Full Text] [Related]
25. Regulation of fluid reabsorption in rat or mouse proximal renal tubules by asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase 1.
Bell T; Araujo M; Luo Z; Tomlinson J; Leiper J; Welch WJ; Wilcox CS
Am J Physiol Renal Physiol; 2018 Jul; 315(1):F74-F78. PubMed ID: 29513072
[TBL] [Abstract][Full Text] [Related]
26. Dimethylarginine dimethylaminohydrolase-1 transgenic mice are not protected from ischemic stroke.
Leypoldt F; Choe CU; Gelderblom M; von Leitner EC; Atzler D; Schwedhelm E; Gerloff C; Sydow K; Böger RH; Magnus T
PLoS One; 2009 Oct; 4(10):e7337. PubMed ID: 19809508
[TBL] [Abstract][Full Text] [Related]
27. Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice.
Li Volti G; Salomone S; Sorrenti V; Mangiameli A; Urso V; Siarkos I; Galvano F; Salamone F
Cardiovasc Diabetol; 2011 Jul; 10():62. PubMed ID: 21756303
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y
Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
[TBL] [Abstract][Full Text] [Related]
29. Preservation of vascular DDAH activity contributes to the protection of captopril against endothelial dysfunction in hyperlipidemic rabbits.
Lin Y; Feng M; Lu CW; Lei YP; He ZM; Xiong Y
Eur J Pharmacol; 2017 Mar; 798():43-48. PubMed ID: 28163022
[TBL] [Abstract][Full Text] [Related]
30. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction.
Jiang DJ; Jia SJ; Yan J; Zhou Z; Yuan Q; Li YJ
Biochem Biophys Res Commun; 2006 Oct; 349(2):683-93. PubMed ID: 16959216
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.
Sharma S; Smith A; Kumar S; Aggarwal S; Rehmani I; Snead C; Harmon C; Fineman J; Fulton D; Catravas JD; Black SM
Vascul Pharmacol; 2010; 52(5-6):182-90. PubMed ID: 19962451
[TBL] [Abstract][Full Text] [Related]
32. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure.
Feng Q; Lu X; Fortin AJ; Pettersson A; Hedner T; Kline RL; Arnold JM
Cardiovasc Res; 1998 Mar; 37(3):667-75. PubMed ID: 9659450
[TBL] [Abstract][Full Text] [Related]
33. all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase.
Achan V; Tran CT; Arrigoni F; Whitley GS; Leiper JM; Vallance P
Circ Res; 2002 Apr; 90(7):764-9. PubMed ID: 11964368
[TBL] [Abstract][Full Text] [Related]
34. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
[TBL] [Abstract][Full Text] [Related]
35. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
Liu LH; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
Cell Physiol Biochem; 2012; 30(6):1413-22. PubMed ID: 23171931
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction.
McCarty MF
Med Hypotheses; 2004; 63(4):699-708. PubMed ID: 15325021
[TBL] [Abstract][Full Text] [Related]
37. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence.
Dayoub H; Achan V; Adimoolam S; Jacobi J; Stuehlinger MC; Wang BY; Tsao PS; Kimoto M; Vallance P; Patterson AJ; Cooke JP
Circulation; 2003 Dec; 108(24):3042-7. PubMed ID: 14638548
[TBL] [Abstract][Full Text] [Related]
38. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor.
Böger RH
J Nutr; 2004 Oct; 134(10 Suppl):2842S-2847S; discussion 2853S. PubMed ID: 15465797
[TBL] [Abstract][Full Text] [Related]
39. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Selley ML
J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
[TBL] [Abstract][Full Text] [Related]
40. The DDAH/ADMA/NOS pathway.
Tran CT; Leiper JM; Vallance P
Atheroscler Suppl; 2003 Dec; 4(4):33-40. PubMed ID: 14664901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
